Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
68°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Stocks making the biggest moves premarket: UPS, Lucid, Beyond Meat, Novo Nordisk and more
August 08, 2023
Tags
Truist Financial Corp
Goldman Sachs Group Inc
Home Depot Inc
From
CNBC.com News
Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials
July 27, 2023
Tags
Clinical trials
Health & Science
Novo Nordisk A/S
From
CNBC.com News
UK investigates weight loss, diabetes drugs like Wegovy and Ozempic for suicide risks
July 26, 2023
Tags
Health & Science
Sanofi SA
Novo Nordisk A/S
From
CNBC.com News
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
July 26, 2023
Tags
Business
Biotech and Pharmaceuticals
Europe: Top News And Analysis
From
CNBC.com News
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
July 14, 2023
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
July 13, 2023
Tags
Congress
Politics
Companies
From
CNBC.com News
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
July 11, 2023
Tags
Pfizer Inc
Diabetes
Health & Science
From
CNBC.com News
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
July 11, 2023
Tags
Weight management
Breaking news
Companies
From
CNBC.com News
Stocks making the biggest moves midday: Shutterstock, Newell Brands, Zillow and more
July 11, 2023
Tags
Xpeng Inc
JPMorgan Chase & Co
Newell Brands Inc
From
CNBC.com News
European regulator to review weight-loss drugs following reports of suicidal thoughts
July 10, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health Care Supplies
From
CNBC.com News
Moderna strikes deal to develop mRNA drugs in China
July 05, 2023
Tags
Health & Science
Sanofi SA
Pfizer Inc
From
CNBC.com News
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
June 30, 2023
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
June 28, 2023
Tags
Business
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says
June 26, 2023
Tags
Biotech and Pharmaceuticals
Business
Eli Lilly and Co
From
CNBC.com News
Novo Nordisk says high-dose experimental obesity pill leads to 15% weight loss
June 26, 2023
Tags
Companies
Breaking news
Science
From
CNBC.com News
Pfizer to end development of experimental obesity pill due to elevated liver enzymes
June 26, 2023
Tags
Biotechnology
US: News
Business News
From
CNBC.com News
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
June 20, 2023
Tickers
LAW
LAWS
Tags
Law and Regulation
Business News
Biotechnology
From
CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
Tags
Obesity
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
May 10, 2023
Tags
Eli Lilly and Co
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Novo Nordisk cuts some U.S. supply of Wegovy obesity drug as demand soars
May 04, 2023
Tags
Medicine
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Obesity drug industry could be worth $200 billion within the decade, says Barclays, as market valuations grow
April 28, 2023
Tags
Health Care Services
Pharmaceuticals
Biotechnology
From
CNBC.com News
Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds
April 27, 2023
Tags
Eli Lilly and Co
US Economy
Business
From
CNBC.com News
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
April 21, 2023
Tags
Breaking News: Business
Congress
Policy
From
CNBC.com News
Senate legislation would cap insulin at $35 per month for people with private insurance
April 21, 2023
Tags
Pandemics
US Economy
U/S/ Economy
From
CNBC.com News
Stocks making the biggest moves midday: Apple, Tesla, Netflix, Bed Bath & Beyond & more
April 13, 2023
Tags
Alibaba Group Holding Ltd
Chipotle Mexican Grill Inc
Steven Madden Ltd
From
CNBC.com News
Stocks making the biggest premarket moves: Delta, First Solar, Steve Madden & more
April 13, 2023
Tags
stocks
Delta Air Lines Inc
Stock markets
From
CNBC.com News
Health misinformation is lowering U.S. life expectancy, FDA Commissioner Robert Califf says
April 11, 2023
Tags
Eli Lilly and Co
Emergent BioSolutions Inc
Health & Science
From
CNBC.com News
People taking obesity drugs Ozempic and Wegovy gain weight once they stop medication
March 29, 2023
Tags
Novo Nordisk A/S
Pharmaceuticals
Health care industry
From
CNBC.com News
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
March 16, 2023
Tags
Breaking News: Business
Breaking news
Health care industry
From
CNBC.com News
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
March 14, 2023
Tags
Breaking news
Breaking News: Business
Health & Science
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.